| 2.9 |
14.7 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 1.4 |
4.3 |
GO:0001803 |
antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 1.3 |
4.0 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 1.2 |
3.6 |
GO:0008228 |
opsonization(GO:0008228) |
| 1.2 |
3.5 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 1.2 |
3.5 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 1.1 |
4.2 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) negative regulation of synaptic transmission, dopaminergic(GO:0032227) cellular response to copper ion(GO:0071280) regulation of peroxidase activity(GO:2000468) |
| 0.8 |
5.9 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.8 |
2.4 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.8 |
2.3 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.8 |
2.3 |
GO:1901228 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.7 |
2.2 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.7 |
2.0 |
GO:2001139 |
negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
| 0.6 |
1.9 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.6 |
3.8 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.6 |
1.2 |
GO:0014062 |
regulation of serotonin secretion(GO:0014062) |
| 0.6 |
1.9 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.6 |
3.7 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.6 |
2.4 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.6 |
1.8 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.6 |
4.6 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 0.5 |
1.6 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.5 |
1.5 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.5 |
1.5 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.5 |
1.5 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) interleukin-1 alpha secretion(GO:0050703) |
| 0.5 |
1.9 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.5 |
1.9 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.5 |
1.4 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.5 |
1.8 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 0.4 |
1.3 |
GO:0046544 |
regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) development of secondary male sexual characteristics(GO:0046544) |
| 0.4 |
1.8 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.4 |
2.2 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) negative regulation of cytolysis(GO:0045918) |
| 0.4 |
1.7 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.4 |
1.7 |
GO:0010813 |
neuropeptide catabolic process(GO:0010813) dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.4 |
1.3 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.4 |
1.2 |
GO:0002586 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
| 0.4 |
2.0 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.4 |
0.8 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.4 |
1.2 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.4 |
3.1 |
GO:0042435 |
indole-containing compound biosynthetic process(GO:0042435) |
| 0.4 |
1.8 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.4 |
1.8 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.4 |
1.1 |
GO:1904395 |
positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.4 |
1.8 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.4 |
1.4 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.4 |
1.1 |
GO:0009193 |
pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
| 0.4 |
1.1 |
GO:0042939 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.4 |
2.1 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.3 |
2.0 |
GO:1903275 |
positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.3 |
0.3 |
GO:0003104 |
positive regulation of glomerular filtration(GO:0003104) |
| 0.3 |
1.0 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.3 |
1.6 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.3 |
0.6 |
GO:0032701 |
negative regulation of interleukin-18 production(GO:0032701) |
| 0.3 |
0.9 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.3 |
0.3 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.3 |
0.9 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) negative regulation of lymphocyte migration(GO:2000402) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.3 |
2.8 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.3 |
1.8 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.3 |
1.8 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.3 |
1.2 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.3 |
1.5 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.3 |
0.9 |
GO:0035441 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) cell migration involved in vasculogenesis(GO:0035441) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) ganglion morphogenesis(GO:0061552) regulation of retinal ganglion cell axon guidance(GO:0090259) positive regulation of retinal ganglion cell axon guidance(GO:1902336) dorsal root ganglion morphogenesis(GO:1904835) |
| 0.3 |
1.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.3 |
0.8 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.3 |
1.4 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.3 |
2.4 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.3 |
1.9 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.3 |
0.8 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.3 |
1.1 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.3 |
1.6 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.3 |
0.8 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.3 |
0.8 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.3 |
0.8 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.3 |
1.5 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.3 |
1.8 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.2 |
1.0 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.2 |
1.0 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.2 |
0.7 |
GO:0035552 |
oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.2 |
1.5 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.2 |
0.7 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.2 |
0.7 |
GO:2001013 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.2 |
1.3 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 |
0.7 |
GO:2000564 |
CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.2 |
0.4 |
GO:0002351 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) beta selection(GO:0043366) |
| 0.2 |
1.3 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.2 |
1.3 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.2 |
0.2 |
GO:0032898 |
neurotrophin production(GO:0032898) |
| 0.2 |
1.9 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.2 |
1.1 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.2 |
7.5 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.2 |
2.7 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.2 |
0.6 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.2 |
0.6 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 0.2 |
0.6 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.2 |
0.6 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.2 |
0.6 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 0.2 |
0.8 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.2 |
0.6 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
2.5 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.2 |
0.4 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.2 |
0.6 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.2 |
0.8 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.2 |
1.1 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.2 |
1.1 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.2 |
0.6 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) |
| 0.2 |
0.4 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.2 |
0.2 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 |
0.7 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.2 |
0.4 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.2 |
0.5 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 |
0.5 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.2 |
0.7 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.2 |
1.1 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 0.2 |
1.4 |
GO:1901534 |
positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.2 |
1.5 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
0.5 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.2 |
1.0 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.2 |
1.0 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.2 |
0.5 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.2 |
1.7 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
1.0 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.2 |
1.3 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.2 |
0.3 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 |
1.8 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.2 |
0.6 |
GO:0060266 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.2 |
0.2 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 0.2 |
0.5 |
GO:0002606 |
positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.2 |
0.2 |
GO:0051712 |
positive regulation of killing of cells of other organism(GO:0051712) |
| 0.2 |
1.5 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.2 |
0.2 |
GO:0036482 |
neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.2 |
0.8 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.2 |
0.8 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
0.6 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.1 |
0.4 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 0.1 |
0.6 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.1 |
0.9 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.1 |
0.3 |
GO:0034331 |
cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
| 0.1 |
0.6 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.1 |
0.4 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 0.1 |
0.6 |
GO:0098763 |
mitotic cell cycle phase(GO:0098763) |
| 0.1 |
2.5 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.1 |
0.1 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.1 |
2.0 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.1 |
GO:1901295 |
regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of heart induction(GO:1901321) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
| 0.1 |
2.7 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.6 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.1 |
0.3 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.1 |
0.3 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.1 |
0.4 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.1 |
0.4 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.1 |
0.5 |
GO:0021612 |
facial nerve structural organization(GO:0021612) |
| 0.1 |
0.8 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.7 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.1 |
0.4 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.1 |
1.5 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.1 |
0.9 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.1 |
0.9 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 |
0.4 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.1 |
0.5 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
1.4 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.4 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.1 |
0.4 |
GO:0060785 |
regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 0.1 |
0.5 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 |
0.5 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.1 |
0.8 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.1 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.1 |
0.5 |
GO:1900110 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.1 |
1.4 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.9 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 |
1.5 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.1 |
0.7 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.9 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.4 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.1 |
0.4 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 0.1 |
2.2 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 |
0.4 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.1 |
0.9 |
GO:1902947 |
regulation of tau-protein kinase activity(GO:1902947) |
| 0.1 |
0.4 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.1 |
1.4 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.1 |
1.7 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.1 |
0.5 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.1 |
0.4 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 0.1 |
0.6 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.2 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
| 0.1 |
0.6 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.1 |
0.7 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.1 |
0.2 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.1 |
0.4 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.6 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 |
2.3 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.1 |
0.5 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.1 |
0.3 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
0.5 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.1 |
0.7 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 |
0.5 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.3 |
GO:0021557 |
oculomotor nerve development(GO:0021557) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.1 |
0.5 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.3 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.1 |
0.3 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.1 |
0.2 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.1 |
0.1 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.1 |
0.2 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
1.1 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.3 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.1 |
0.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.5 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.1 |
0.2 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.1 |
0.3 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.1 |
0.2 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
0.3 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.2 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.1 |
0.4 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.5 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
1.1 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.1 |
0.4 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 |
0.2 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
0.1 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.1 |
0.9 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.1 |
0.4 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.1 |
0.3 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.1 |
1.0 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.2 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.4 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
| 0.1 |
1.6 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.1 |
0.8 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.2 |
GO:0048682 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 0.1 |
0.7 |
GO:0045862 |
positive regulation of proteolysis(GO:0045862) |
| 0.1 |
0.7 |
GO:0016137 |
glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
| 0.1 |
0.2 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.1 |
0.4 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.4 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.1 |
0.7 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.1 |
0.6 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.1 |
0.3 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.1 |
0.6 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.1 |
0.8 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
1.1 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
0.9 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.1 |
1.1 |
GO:1903020 |
positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.1 |
0.4 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 |
0.4 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
1.1 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 |
0.7 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 |
0.2 |
GO:0042637 |
catagen(GO:0042637) |
| 0.1 |
1.1 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
6.2 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.1 |
0.4 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.1 |
0.3 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 |
0.8 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 |
0.3 |
GO:0060709 |
glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
| 0.1 |
0.4 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.7 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.8 |
GO:0042523 |
positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
| 0.1 |
0.6 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.1 |
4.3 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.1 |
0.1 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.1 |
0.2 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.2 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
0.4 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.1 |
0.7 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.3 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.1 |
0.3 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 |
0.4 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.1 |
0.2 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 |
0.5 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 |
1.1 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.6 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 |
0.9 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
0.2 |
GO:0019184 |
nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.1 |
0.5 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.6 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.8 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.3 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
1.2 |
GO:0072575 |
hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
| 0.1 |
0.6 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.1 |
0.2 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.1 |
0.2 |
GO:0051798 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.1 |
0.5 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.2 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.1 |
0.1 |
GO:0032466 |
negative regulation of cytokinesis(GO:0032466) |
| 0.1 |
0.8 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
0.1 |
GO:0009838 |
abscission(GO:0009838) |
| 0.1 |
0.1 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.1 |
0.7 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
0.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.6 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
0.5 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.1 |
0.2 |
GO:2001274 |
negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 |
0.4 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.1 |
0.1 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.1 |
0.4 |
GO:0046864 |
retinol transport(GO:0034633) nose morphogenesis(GO:0043585) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
| 0.1 |
1.6 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.1 |
0.5 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 |
0.6 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.4 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.1 |
0.2 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.3 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 |
0.8 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.1 |
0.6 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.1 |
0.3 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.1 |
1.1 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.1 |
0.3 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.1 |
0.3 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
0.2 |
GO:0002677 |
negative regulation of chronic inflammatory response(GO:0002677) |
| 0.1 |
0.8 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 |
0.8 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.1 |
0.9 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 |
0.7 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 |
0.5 |
GO:0045040 |
outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 |
0.2 |
GO:0039521 |
lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) late nucleophagy(GO:0044805) negative regulation of sphingolipid biosynthesis involved in cellular sphingolipid homeostasis(GO:0090157) |
| 0.1 |
0.9 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
0.4 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 |
1.1 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.1 |
1.3 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.1 |
1.6 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
0.3 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.1 |
0.3 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
0.4 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.1 |
0.1 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
1.3 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.1 |
0.2 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
0.6 |
GO:0021684 |
cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
1.4 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.1 |
0.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
0.1 |
GO:0010872 |
regulation of cholesterol esterification(GO:0010872) |
| 0.1 |
1.3 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.1 |
0.6 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.1 |
0.7 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
0.6 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.1 |
0.1 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.1 |
0.3 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
0.4 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.1 |
0.3 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
0.2 |
GO:0043649 |
dicarboxylic acid catabolic process(GO:0043649) |
| 0.1 |
0.6 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 |
0.9 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.1 |
0.4 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.8 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.5 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.1 |
0.5 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.7 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.1 |
2.5 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.1 |
0.4 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.2 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.1 |
1.0 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.1 |
0.5 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.1 |
0.2 |
GO:0010561 |
negative regulation of glycoprotein biosynthetic process(GO:0010561) |
| 0.1 |
0.4 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
0.5 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
0.2 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 |
0.4 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.1 |
0.4 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.5 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.1 |
0.3 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.1 |
0.3 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 0.1 |
0.2 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 |
0.5 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.1 |
0.9 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
0.9 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.1 |
1.0 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.3 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.1 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.1 |
0.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
0.2 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 |
0.3 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.1 |
1.4 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.2 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.3 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 |
0.3 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 |
0.3 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.0 |
0.4 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.0 |
0.3 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.7 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.0 |
1.1 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.0 |
0.2 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.0 |
0.1 |
GO:0048296 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
| 0.0 |
0.4 |
GO:0099625 |
regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
| 0.0 |
0.6 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
0.1 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.0 |
1.3 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
1.4 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.3 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.0 |
0.6 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.0 |
0.3 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 |
1.7 |
GO:0006818 |
hydrogen transport(GO:0006818) |
| 0.0 |
0.1 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.0 |
1.4 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 |
0.2 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.0 |
0.3 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.4 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.3 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.0 |
0.6 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.0 |
0.8 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.2 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) |
| 0.0 |
0.2 |
GO:0060456 |
positive regulation of digestive system process(GO:0060456) |
| 0.0 |
0.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.1 |
GO:0036093 |
male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.0 |
1.1 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.2 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 |
0.5 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 |
0.8 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 |
0.3 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.2 |
GO:0002716 |
negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.0 |
0.1 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.0 |
0.4 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.2 |
GO:0032691 |
negative regulation of interleukin-1 beta production(GO:0032691) |
| 0.0 |
0.3 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
| 0.0 |
0.2 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 |
0.2 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.0 |
0.3 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.0 |
0.2 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.1 |
GO:0003161 |
cardiac conduction system development(GO:0003161) |
| 0.0 |
0.4 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
0.1 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.0 |
0.1 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.4 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.0 |
0.2 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.0 |
0.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.0 |
0.0 |
GO:0071639 |
positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.0 |
0.0 |
GO:0060676 |
ureteric bud formation(GO:0060676) |
| 0.0 |
0.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.2 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of endoribonuclease activity(GO:0060699) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.0 |
0.1 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.0 |
0.4 |
GO:1902624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
| 0.0 |
0.2 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.0 |
0.4 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.2 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.0 |
0.2 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.0 |
0.0 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 |
0.1 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.0 |
0.3 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.3 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.5 |
GO:1901032 |
negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.0 |
0.1 |
GO:0060126 |
somatotropin secreting cell differentiation(GO:0060126) |
| 0.0 |
0.5 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.5 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.1 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.0 |
0.1 |
GO:0046985 |
histone H3-K4 acetylation(GO:0043973) positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.0 |
0.7 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.0 |
0.5 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.0 |
0.2 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.0 |
0.2 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
1.0 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 |
0.2 |
GO:0051608 |
organic cation transport(GO:0015695) histamine transport(GO:0051608) |
| 0.0 |
0.2 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.5 |
GO:0045471 |
response to ethanol(GO:0045471) |
| 0.0 |
0.2 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.0 |
0.1 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.0 |
0.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.4 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.2 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.6 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.3 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.0 |
0.1 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.0 |
0.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.4 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.3 |
GO:0003179 |
heart valve morphogenesis(GO:0003179) |
| 0.0 |
0.5 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.0 |
0.4 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 |
0.1 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 |
0.1 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.0 |
0.2 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.1 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.0 |
0.6 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.7 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 |
0.2 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.0 |
0.2 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.3 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
1.7 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.0 |
0.2 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.0 |
0.1 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.0 |
0.3 |
GO:0022904 |
respiratory electron transport chain(GO:0022904) |
| 0.0 |
0.2 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 |
0.1 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 |
0.2 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.0 |
0.3 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.1 |
GO:0036481 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.0 |
0.9 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.1 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.0 |
0.4 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0000429 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.0 |
0.5 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.0 |
0.1 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 |
0.7 |
GO:0048524 |
positive regulation of viral process(GO:0048524) |
| 0.0 |
0.4 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.6 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.1 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.0 |
0.2 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 |
0.2 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.1 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
0.0 |
GO:0071033 |
nuclear retention of pre-mRNA at the site of transcription(GO:0071033) CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.0 |
0.3 |
GO:0060438 |
trachea development(GO:0060438) |
| 0.0 |
0.3 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.0 |
0.1 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.7 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.5 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.0 |
0.2 |
GO:1900364 |
negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 |
0.6 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.0 |
0.1 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.0 |
0.0 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.0 |
0.9 |
GO:0043525 |
positive regulation of neuron apoptotic process(GO:0043525) |
| 0.0 |
0.1 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.0 |
0.1 |
GO:0051785 |
positive regulation of mitotic nuclear division(GO:0045840) positive regulation of nuclear division(GO:0051785) |
| 0.0 |
0.2 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.0 |
0.2 |
GO:0044243 |
multicellular organism catabolic process(GO:0044243) |
| 0.0 |
0.3 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.0 |
0.2 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.1 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.3 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.0 |
0.2 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.0 |
0.1 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.1 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.0 |
0.3 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.0 |
0.3 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.0 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.0 |
0.3 |
GO:0043153 |
photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 |
0.2 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.0 |
0.2 |
GO:0032720 |
negative regulation of tumor necrosis factor production(GO:0032720) |
| 0.0 |
0.2 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.2 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 |
0.5 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.0 |
0.1 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 |
0.1 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.1 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.0 |
0.4 |
GO:0051591 |
response to cAMP(GO:0051591) |
| 0.0 |
0.1 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.0 |
0.0 |
GO:0032305 |
positive regulation of icosanoid secretion(GO:0032305) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.0 |
0.1 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.0 |
0.2 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.7 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.1 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.0 |
0.1 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 |
0.1 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.0 |
0.1 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.1 |
GO:0019395 |
fatty acid oxidation(GO:0019395) |
| 0.0 |
0.2 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.0 |
0.1 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
0.0 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.0 |
0.0 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
0.0 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.0 |
0.2 |
GO:0055012 |
ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.0 |
0.2 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.3 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.1 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
0.1 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 |
0.1 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.0 |
0.1 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
| 0.0 |
0.1 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.0 |
0.1 |
GO:0035383 |
acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.0 |
0.4 |
GO:0051289 |
protein homotetramerization(GO:0051289) |
| 0.0 |
0.1 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.1 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.0 |
0.1 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.1 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.0 |
0.4 |
GO:0051453 |
regulation of intracellular pH(GO:0051453) |
| 0.0 |
0.7 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.0 |
0.0 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.0 |
0.1 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.0 |
0.1 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.3 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.2 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.2 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.1 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.0 |
0.2 |
GO:0008344 |
adult locomotory behavior(GO:0008344) |
| 0.0 |
0.1 |
GO:0006677 |
glycosylceramide metabolic process(GO:0006677) |
| 0.0 |
0.1 |
GO:0051974 |
negative regulation of telomerase activity(GO:0051974) |
| 0.0 |
0.1 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.0 |
0.2 |
GO:0048002 |
antigen processing and presentation of peptide antigen(GO:0048002) |
| 0.0 |
0.1 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.0 |
0.1 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.0 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 |
0.1 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.3 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.0 |
0.0 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 |
0.0 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.0 |
0.1 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.1 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.1 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.0 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.0 |
0.1 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.0 |
0.1 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
